MétaCan
Menu
Back to cohort
Record W2062718003 · doi:10.1016/j.bbmt.2014.06.019

Outcomes after Hematopoietic Stem Cell Transplantation for Children with I-Cell Disease

2014· article· en· W2062718003 on OpenAlexaff
Troy C. Lund, Sara Cathey, Weston P. Miller, Mary Eapen, Martin Andreánsky, Christopher C. Dvorak, Jeffrey Davis, Jignesh Dalal, Steven M. Devine, Gretchen Eames, William S. Ferguson, Roger Giller, Wensheng He, Joanne Kurtzberg, Robert A. Krance, Emmanuel Katsanis, Victor Lewis, Indira Sahdev, Paul J. Orchard

Bibliographic record

VenueBiology of Blood and Marrow Transplantation · 2014
Typearticle
Languageen
FieldMedicine
TopicLysosomal Storage Disorders Research
Canadian institutionsAlberta Children's HospitalBC Children's HospitalUniversity of British Columbia
FundersNational Cancer InstituteOffice of Naval ResearchNational Heart, Lung, and Blood InstituteTerumo BCTHealth Resources and Services AdministrationMedacSwedish Orphan BiovitrumOtsuka AmericaIncyteGenentechSeattle GeneticsChimerixMedical College of WisconsinBlue Cross and Blue Shield AssociationTakeda OncologyUniversity of MinnesotaKiadis PharmaSigma-Tau PharmaceuticalsTherakosStemCyteTarix PharmaceuticalsUniversity of UtahHistoGeneticsWellPointTeva Pharmaceutical IndustriesNational Marrow Donor ProgramSt. Baldrick's FoundationNational Institute of Allergy and Infectious DiseasesRoswell Park Cancer InstituteFred Hutchinson Cancer Research CenterHealth ResearchU.S. NavyCelgeneOsiris TherapeuticsMerckGlaxoSmithKlineLeukemia and Lymphoma SocietyBe The Match FoundationAllos TherapeuticsActinium PharmaceuticalsAriad PharmaceuticalsOtsuka America PharmaceuticalAmgenOnyx PharmaceuticalsU.S. Department of DefenseSanofi
KeywordsMedicineHematopoietic stem cell transplantationDiseaseStem cellTransplantationLysosomal storage diseaseHematopoietic stem cellCause of deathHaematopoiesisPediatricsIntensive care medicineInternal medicineSurgery

Abstract

fetched live from OpenAlex

Mucolipidosis type II (MLII), or I-cell disease, is a rare but severe disorder affecting localization of enzymes to the lysosome, generally resulting in death before the 10th birthday. Although hematopoietic stem cell transplantation (HSCT) has been used to successfully treat some lysosomal storage diseases, only 2 cases have been reported on the use of HSCT to treat MLII. For the first time, we describe the combined international experience in the use of HSCT for MLII in 22 patients. Although 95% of the patients engrafted, overall survival was low, with only 6 patients (27%) alive at last follow-up. The most common cause of death post-transplant was cardiovascular complications, most likely due to disease progression. Survivors were globally delayed in development and often required complex medical support, such as gastrostomy tubes for nutrition and tracheostomy with mechanical ventilation. Although HSCT has demonstrated efficacy in treating some lysosomal storage disorders, the neurologic outcome and survival for patents with MLII were poor. Therefore, new medical and cellular therapies should be sought for these patients.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.002
Threshold uncertainty score0.005

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.001
Science and technology studies0.0010.000
Scholarly communication0.0010.000
Open science0.0000.001
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.008
GPT teacher head0.240
Teacher spread0.232 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations35
Published2014
Admission routes1
Has abstractyes

Explore more

Same venueBiology of Blood and Marrow TransplantationSame topicLysosomal Storage Disorders ResearchFrench-language works237,207